Associated Papers
Engineering of a high-fidelity Cas12a nuclease variant capable of allele-specific editing.
Wei J et al.
Plos Biology, 2024
38865309 (PubMed )
Supplement: pbio.3002680.s016.xlsx › ClinVar
Aggressive Squamous Cell Carcinoma in a Case of Epidermodysplasia Verruciformis Carrying a TMC6 Splice-site Mutation.
Yokoi K et al.
Acta Dermato-venereologica, 2023
Identification and Splicing Characterization of Novel TMC6 and TMC8 Variants Associated With Epidermodysplasia Verruciformis in Three Chinese Families.
Wang R et al.
Frontiers in Genetics, 2021
34386043 (PubMed )
Supplement: Data_Sheet_1.docx
The EVER genes - the genetic etiology of carcinogenesis in epidermodysplasia verruciformis and a possible role in non-epidermodysplasia verruciformis patients.
Kalińska-Bienias A et al.
Postepy Dermatologii I Alergologii, 2016
Epidermodysplasia verruciformis.
Burger B et al.
Current Problems in Dermatology, 2014
Common variable immunodeficiency syndrome associated with epidermodysplasia verruciformis.
Vu J et al.
American Journal of Clinical Dermatology, 2007
Identification of a novel mutation and a genetic polymorphism of EVER1 gene in two families with epidermodysplasia verruciformis.
Zuo YG et al.
Journal of Dermatological Science, 2006
Four mutations in Epidermodysplasia verruciformis 1 (EVER1) gene are not contributors to susceptibility in RRP.
Donfack J et al.
International Journal of Pediatric Otorhinolaryngology, 2006
A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis.
Sun XK et al.
Clinical and Experimental Dermatology, 2005
Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis.
Tate G et al.
Journal of Human Genetics, 2004
Select a paper to view details